HomeNewsBusinessStartupCoronavirus pandemic | Jet-setting VCs settle down for a more ‘grounded’ reality

Coronavirus pandemic | Jet-setting VCs settle down for a more ‘grounded’ reality

Even after the situation gets normal, they will travel less as more meetings and deal-making will happen over video calls.

May 19, 2020 / 11:31 IST
Story continues below Advertisement
Representative image
Representative image

In 2019, a partner at a venture capital fund used the airline miles he had accumulated over the years to book tickets for a summer holiday in Europe for his in-laws. For 10 years, the partner travelled four days a week domestically and was abroad, mostly the US or China, once in a quarter at least.  

Such plans will be much more difficult to pull off in a world hit with the coronavirus that has restricted people’s movement and virtually put a stop to air travel in most parts of the world.

Story continues below Advertisement

Almost every senior venture capitalist in the country is a platinum member of Inter Miles, earlier known as Jet Privilege (when Jet Airways was running), or Air India’s Flying Returns, with both memberships allowing fliers to accrue points even when travelling with partner airlines globally. 

Venture capitalists recount running into each other or startup founders at airports, discussing terms of a deal minutes before taking off. They also recall instances of “hustle”, the catchall term for being at the forefront of the hottest deals. 

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show

Follow LIVE updates on the COVID-19 pandemic here

With the benefit of hindsight, they realise some of that may have been unnecessary.
“Earlier I was taking three flights a week. That will come to three a month now even after lockdown ends and normalcy resumes,” said Pratik Poddar, Principal at Nexus Venture Partners, an early-stage fund.